5 things to know about semaglutide-based meds and addiction treatment

The US FDA approved GLP-1 medications for treating type 2 diabetes and obesity and research is underway on the effectiveness of treating addiction with these medications. Professor Anna Lembke MD of Stanford Medicine, author of Dopamine Nation, shared 5 main takeaways people should know.